306 related articles for article (PubMed ID: 15767499)
1. Molecular pathogenesis of Parkinson disease.
Eriksen JL; Wszolek Z; Petrucelli L
Arch Neurol; 2005 Mar; 62(3):353-7. PubMed ID: 15767499
[TBL] [Abstract][Full Text] [Related]
2. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein and Parkinson's disease: a proteomic view.
Fasano M; Lopiano L
Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
5. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
Calì T; Ottolini D; Brini M
Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Parkinson's disease.
Sherer TB; Betarbet R; Greenamyre JT
Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
[TBL] [Abstract][Full Text] [Related]
10. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
11. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome system and Parkinson's disease.
Olanow CW; McNaught KS
Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
[TBL] [Abstract][Full Text] [Related]
13. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2012 Nov; 53(9):1791-806. PubMed ID: 22967820
[TBL] [Abstract][Full Text] [Related]
14. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
Galvin JE
Acta Neuropathol; 2006 Aug; 112(2):115-26. PubMed ID: 16791599
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].
Ramírez-Jirano LJ; Ruiz-Sandoval JL; Jiménez-Gil FJ; Ramírez-Vega J; Vargas-Frutos E; Gallegos-Arreola MP
Rev Neurol; 2007 Jan 1-15; 44(1):15-7. PubMed ID: 17199224
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
[TBL] [Abstract][Full Text] [Related]
17. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.
Ferrer I
Prog Neurobiol; 2009 Jun; 88(2):89-103. PubMed ID: 19482226
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
Lim KL
Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
[TBL] [Abstract][Full Text] [Related]
20. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
